Shanghai Wd Pharmaceutical Co., Ltd.

This early-stage study is testing how the body handles WD-1603, a combination of carbidopa and levodopa used for Parkinson's disease, when taken at different time intervals. Twelve healthy adults will take the drug twice a day on three separate days, with gaps of 5, 6, or 7 hours…